SEARCH

SEARCH BY CITATION

References

  • 1
    Consensus statement on indication for liver transplantation, Paris, June 22–23,1993. Hepatology 1994; 20(1 pt 2): 63S68S.
  • 2
    Stevens L, Piper J, Emond J, Heffron T, Baker A, Broelsch C. Liver transplantation for controversial indications: Alcoholic liver disease, hepatic cancer, and viral hepatitis. Transpl Proc 1991; 23: 19151916.
  • 3
    Van Thiel DH, Carr B, Iwatsuki S, Tzakis A, Fung JJ, Starzl TE. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transpl Proc 1991; 23: 19171921.
  • 4
    Starzl TE, Demetris AJ, Van Thiel DH. Liver transplantation. N Engl J Med 1989; 321: 10921099.
  • 5
    Villamil FG, Vierling JM. Recurrence of viral hepatitis following liver transplantation: Insight into management. Liv Transpl Surg 1995; 5(Suppl 1): 8999.
  • 6
    Demetris AJ, Jaffe R, Sheahan DG, Burnham J, Spero J, Iwatsuki S, et al. Recurrent hepatitis B in liver allograft recipients. Am J Pathol 1986; 125: 161172.
  • 7
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992; 14: 104111.
  • 8
    Martin P, Friedman LS. Recurrent hepatitis B in liver transplant recipients—no easy answers. Gastroenterol 1991; 101: 11311133.
  • 9
    Bäckman L, Gibbs J, Levy M, McMillian R, Holman M, Husberg B, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55: 10781082.
  • 10
    Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, et al. Liver transplantation in Hbs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 9096.
  • 11
    Samuel D, Bismuth A, Serres C, Arulnaden JL, Reynes M, Benhamou JP, et al. HBV infection after liver transplantation in HBsAg positive patients: Experience with long-term immunoprophylaxis. Lancet 1991; 337: 813815.
  • 12
    Norusis MJ. SPSS/PC+ User's Guide, Version 5.0. Chicago, IL, SPSS, Inc, 1992.
  • 13
    Hopkins A. Survival analysis with covariates. In: DixonWJ, BrownMB, EngelmanL, JennrichRI (eds). BMDP statistical software. Berkeley, University of California Press, 1993; 769806.
  • 14
    Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 18421847.
  • 15
    Freeman RB, Sanchez H, Lewis WD, Sherburne B, Dzik WH, Khettry U, et al. Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation 1991; 51: 793797.
  • 16
    Lauchart W, Müller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 23872389.
  • 17
    Feray C, Zignego AL, Samuel D. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection: The liver transplantation model. Transplantation 1990; 49: 11551158.
  • 18
    Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B? Yes! Liver Transpl Surg 1995; 1: 260265.
  • 19
    König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, et al. Long term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58: 553559.
  • 20
    Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995; 1: 3042.
  • 21
    Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H Jr., Retransplantation in hepatitis B—A multicenter experience. Transplantation 1994; 57: 823826.
  • 22
    Ishitani M, McGory R, Dickson R, Caldwell S, McCullough C, Stevenson W, et al. Successful retransplantation for severe post-transplant hepatitis B virus (HBV) infection in the primary allograft. Liver Transpl Surg 1995; 1: 448.
  • 23
    Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23: 17.
  • 24
    Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995; 59: 16291630.
  • 25
    Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, et al. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation 1994; 58: 183191.
  • 26
    Bartholomew M, Vicary C, Roach K, Jeffers LJ, Bernstein D, de Medina M, et al. Use of lamivudine in the treatment of recurrent hepatitis B infection post-liver transplantation. Gastroenterology 1995; 108: A1030.